TY - JOUR AB - Cervical cancer (CC) is a public health problem worldwide, including Mexico. This type of cancer is the fourth most frequent in women worldwide; in Mexico it is the second most common type in women after breast cancer. The diagnosis of CC is based mainly on Pap smears and colposcopy and the identification of molecular tools that serve as a support for these methods is urgent. Regarding this, differential expressions of specific circulating biomolecules has been detected and, based on this, they have been postulated as potential biomarkers for CC diagnosis, prognosis, and/or to identify the response to treatments. Importantly, the combined analysis of these molecules considerably improves their efficacy as biomarkers and their potential use in the medical attention is promising. AD - Investigadora por México, Non-coding RNAs Laboratory, Medical Research Unit in Human Genetics, Children's Hospital ‘Dr. Silvestre Frenk Freund’, National Medical Center XXI Century, Mexican Institute of Social (Instituto Mexicano del Seguro Social, IMSS), Doctores, Mexico City 06720, Mexico ATSO PHARMA Laboratory, Jardines del Pedregal, Álvaro Obregón, Mexico City 01900, Mexico Non-coding RNAs Laboratory, Medical Research Unit in Human Genetics, Children's Hospital ‘Dr. Silvestre Frenk Freund’, National Medical Center XXI Century, Mexican Institute of Social (Instituto Mexicano del Seguro Social, IMSS), Doctores, Mexico City 06720, Mexico AU - Ruiz Esparza Garrido,Ruth AU - Gutiérrez,Mercedes AU - Velázquez Flores,Miguel,Ángel DA - 2023/02/01 DO - 10.3892/mco.2023.2609 IS - 2 JO - Mol Clin Oncol KW - cervical cancer diagnosis prognosis response to treatments circulating biomarker PY - 2023 SN - 2049-9450 2049-9469 SP - 13 ST - Circulating cervical cancer biomarkers potentially useful in medical attention (Review) T2 - Molecular and Clinical Oncology TI - Circulating cervical cancer biomarkers potentially useful in medical attention (Review) UR - https://doi.org/10.3892/mco.2023.2609 VL - 18 ER -